These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8911290)

  • 21. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
    Chakrabarti A; Fleisher WP; Staley D; Calhoun L
    Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caring for older patients: current attitudes and future plans of family medicine residents.
    Helton MR; Pathman DE
    Fam Med; 2008; 40(10):707-14. PubMed ID: 18979258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coping strategies, depression, and anxiety among Ontario family medicine residents.
    Earle L; Kelly L
    Can Fam Physician; 2005 Feb; 51(2):242-3. PubMed ID: 16926935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical representatives and emergency medicine residents: a national survey.
    Reeder M; Dougherty J; White LJ
    Ann Emerg Med; 1993 Oct; 22(10):1593-6. PubMed ID: 8214843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training.
    Guyatt G
    Can Fam Physician; 1997 Nov; 43():1898-900, 1905-7. PubMed ID: 9386871
    [No Abstract]   [Full Text] [Related]  

  • 30. Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry.
    Hyman PL; Hochman ME; Shaw JG; Steinman MA
    Acad Med; 2007 Jan; 82(1):94-9. PubMed ID: 17198299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do ethical Guidelines make a difference to decision-making?
    Osborn M; Day R; Komesaroff P; Mant A
    Intern Med J; 2009 Dec; 39(12):800-5. PubMed ID: 19323704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical industry interactions in family medicine residencies decreased between 2008 and 2013: a CERA study.
    Brown SR; Evans DV; Fugh-Berman A
    Fam Med; 2015 Apr; 47(4):279-82. PubMed ID: 25853598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Closing the door on pharma? A national survey of family medicine residencies regarding industry interactions.
    Fugh-Berman A; Brown SR; Trippett R; Bell AM; Clark P; Fleg A; Siwek J
    Acad Med; 2011 May; 86(5):649-54. PubMed ID: 21436662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intention to relocate to the United States.
    Ma PC; Chan LK; Huynh X
    Can Fam Physician; 1997 Sep; 43():1533-9. PubMed ID: 9303232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
    Castresana L; Mejia R; Aznar M
    Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of osteopathic and allopathic residents' attitudes toward osteopathic manipulative treatment.
    Allee BA; Pollak MH; Malnar KF
    J Am Osteopath Assoc; 2005 Dec; 105(12):551-61. PubMed ID: 16424465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes of general practitioners in New Zealand to pharmaceutical representatives.
    Thomson AN; Craig BJ; Barham PM
    Br J Gen Pract; 1994 May; 44(382):220-3. PubMed ID: 8204336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counseling regarding pregnancy--related drug exposures by family physicians in Ontario.
    Goodwin J; Rieder S; Rieder MJ; Matsui D
    Can J Clin Pharmacol; 2007; 14(1):e58-69. PubMed ID: 17314415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Physicians and drug industry: attitudes and practice].
    Aasland OG; Førde R
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.